help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2003-1015
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haluzik, M.
Right arrow Articles by LeRoith, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haluzik, M.
Right arrow Articles by LeRoith, D.
Endocrinology Vol. 145, No. 4 1662-1667
Copyright © 2004 by The Endocrine Society

Peroxisome Proliferator-Activated Receptor-{alpha} Deficiency Does Not Alter Insulin Sensitivity in Mice Maintained on Regular or High-Fat Diet: Hyperinsulinemic-Euglycemic Clamp Studies

Martin Haluzik, Oksana Gavrilova and Derek LeRoith

Third Department of Medicine (M.H.), First Faculty of Medicine, Charles University, 128 08 Prague 2, Czech Republic; and Mouse Metabolism Laboratory (O.G.) and Diabetes Branch (D.L.), National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-1758

Address all correspondence and requests for reprints to: Martin Haluzik, Third Department of Medicine, First Faculty of Medicine, Charles University, U nemocnice 1, 128 08, Prague 2, Czech Republic. E-mail: mhalu{at}lf1.cuni.cz.

Chronic peroxisome proliferator-activated receptor (PPAR)-{alpha} activation improves glucose metabolism in rodent models of insulin resistance and diabetes; however, PPAR-{alpha} deficiency was also reported to protect against high-fat diet (HFD)-induced insulin resistance. The aim of this study was to clarify the role of PPAR-{alpha} in the development of insulin resistance using PPAR-{alpha} knockout (KO) mice and wild-type controls (WT). Both WT and PPAR-{alpha} KO mice on HFD gained significantly more weight relative to chow-fed groups and displayed an increase in insulin levels and a decrease in adiponectin levels. Hyperinsulinemic-euglycemic clamp performed in the nonfasting state demonstrated that HFD caused a marked reduction in whole body, muscle, and white and brown adipose tissue glucose uptake in both WT and PPAR-{alpha} KO mice relative to chow-fed groups. Suppression of endogenous glucose production during the clamp was markedly blunted in both WT and PPAR-{alpha} KO HFD-fed mice, indicating liver insulin resistance. The magnitude of HFD-induced changes in the clamp parameters of insulin sensitivity was comparable in PPAR-{alpha} KO and WT mice. In conclusion, these data show that PPAR-{alpha} deficiency does not alter insulin sensitivity in mice fed normal chow diet and does not protect against HFD-induced insulin resistance as measured by hyperinsulinemic-euglycemic clamp in nonfasted state.




This article has been cited by other articles:


Home page
DiabetesHome page
D. H. Wasserman, J. E. Ayala, and O. P. McGuinness
Lost in Translation
Diabetes, September 1, 2009; 58(9): 1947 - 1950.
[Full Text] [PDF]


Home page
HypertensionHome page
K. M. Tordjman, C. F. Semenkovich, T. Coleman, R. Yudovich, S. Bak, E. Osher, M. Vechoropoulos, and N. Stern
Absence of Peroxisome Proliferator-Activated Receptor-{alpha} Abolishes Hypertension and Attenuates Atherosclerosis in the Tsukuba Hypertensive Mouse
Hypertension, November 1, 2007; 50(5): 945 - 951.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. C. Noland, J. P. Thyfault, S. T. Henes, B. R. Whitfield, T. L. Woodlief, J. R. Evans, J. A. Lust, S. L. Britton, L. G. Koch, R. W. Dudek, et al.
Artificial selection for high-capacity endurance running is protective against high-fat diet-induced insulin resistance
Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E31 - E41.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Knauf, J. Rieusset, M. Foretz, P. D. Cani, M. Uldry, M. Hosokawa, E. Martinez, M. Bringart, A. Waget, S. Kersten, et al.
Peroxisome Proliferator-Activated Receptor-{alpha}-Null Mice Have Increased White Adipose Tissue Glucose Utilization, GLUT4, and Fat Mass: Role in Liver and Brain
Endocrinology, September 1, 2006; 147(9): 4067 - 4078.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. E. Ayala, D. P. Bracy, O. P. McGuinness, and D. H. Wasserman
Considerations in the Design of Hyperinsulinemic-Euglycemic Clamps in the Conscious Mouse
Diabetes, February 1, 2006; 55(2): 390 - 397.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H.-Y. Lin, Q. Xu, S. Yeh, R.-S. Wang, J. D. Sparks, and C. Chang
Insulin and Leptin Resistance With Hyperleptinemia in Mice Lacking Androgen Receptor
Diabetes, June 1, 2005; 54(6): 1717 - 1725.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society